Vesicular systems for delivering conventional small organic molecules and larger macromolecules to and through human skin

Bibliography

• Barry BW. Dermatological formulations: percutaneous absorption. New York and Basel: Marcel Dekker; 1983
   Google Scholar
• Barry BW. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci 2001;14:101-14
   PubMed Web of Science ®Google Scholar
• Williams AC. Transdermal and topical drug delivery: from theory to clinical practice. London: Pharmaceutical Press; 2003
   Google Scholar
• Williams AC, Barry BW. Penetration enhancers. Adv Drug Del Rev 2004;56:603-18
   PubMed Web of Science ®Google Scholar
• Megrab NA, Williams AC, Barry BW. Oestradiol permeation across human skin and silastic membranes: effects of propylene glycol and supersaturation. J Control Rel 1995;36:277-94
   Web of Science ®Google Scholar
• Leichtnam ML, Rolland H, Wüthrich P, Guy RH. Impact of antinucleants on transdermal delivery of testosterone from a spray. J Pharm Sci 2007;96:84-92
   PubMed Web of Science ®Google Scholar
• Miller LL, Kolaskie CJ, Smith GA, Rivier J. Transdermal iontophoresis of gonadotropin releasing hormone and two analogues. J Pharm Sci 1990;79:490-3
   PubMed Web of Science ®Google Scholar
• Prausnitz MR, Gimm JA, Guy RH, et al. Imaging of transport pathways across human stratum corneum during high-voltage and low-voltage electrical exposures. J Pharm Sci 1996;85:1363-70
   PubMed Web of Science ®Google Scholar
• Kost J, Pliquett U, Mitragotri S, et al. Synergistic effect of electric field and ultrasound on transdermal transport. Pharm Res 1996;13:633-8
   PubMed Web of Science ®Google Scholar
• Kreilgaard M. Influence of microemulsions on cutaneous drug delivery. Adv Drug Deliver Rev 2002;54:S77-98
   PubMed Web of Science ®Google Scholar
• El Maghraby GM. Transdermal delivery of hydrocortisone from eucalyptus oil microemulsion: Effects of cosurfactants. Int J Pharm 2008;355:285-92
   PubMed Web of Science ®Google Scholar
• Mezei M, Gulasekharam V. Liposomes-a selective drug delivery system for topical route of administration. 1. lotion dosage form. Life Sci 1980;26:1473-7
   PubMed Web of Science ®Google Scholar
• Cevc G, Blume G. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim Biophys Acta 1992;1104:226-32
   PubMed Web of Science ®Google Scholar
• Schreier H, Bouwstra J. Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery. J Control Rel 1994;30:1-15
   Web of Science ®Google Scholar
• El Maghraby GM, Williams AC, Barry BW. Can drug bearing liposomes penetrate intact skin? J Pharm Pharmacol 2006;58:415-29
   PubMed Web of Science ®Google Scholar
• Touitou E, Godin B, Weiss C. Enhanced delivery of drugs into and across the skin by ethosomal carriers. Drug Dev Res 2000;50: 406-15
   Web of Science ®Google Scholar
• Touitou E, Dayan N, Bergelson L, et al. Ethosomes: novel vesicular carriers for enhanced delivery: characterisation and skin penetration properties. J Control Rel 2000;65:403-418
   PubMed Web of Science ®Google Scholar
• El Maghbary GM, Williams AC, Barry BW. Liposomes and skin. From drug delivery to model membranes. Eur J Pharm Sci 2008;34:203-22
   PubMed Web of Science ®Google Scholar
• Mezei M, Gulasekharam V. Liposomes-a selective drug delivery system for topical route of administration: gel dosage form. J Pharm Pharmacol 1982;34:473-4
   PubMed Web of Science ®Google Scholar
• Mezei M. Liposomes as a skin drug delivery system. In Breimer DD and Speiser P, editors, Topics in Pharmaceutical Sciences, Elsevier, Amsterdam, New York, Oxford, 1985. p. 345-58
   Google Scholar
• Vermorken AJM, Hukkelhoven MWAC, Vermeesch-marksiag AMG, et al. The use of liposomes in topical application of steroids. J Pharm Pharmacol 1984;36:334-6
   PubMed Web of Science ®Google Scholar
• Wohlrab W, Lasch J, Laub R, et al. Distribution of liposome-encapsulated ingredients in human skin ex vivo. In: Falco OB, Korting HC, Maibach HI, editors, Liposome Dermatics, Springer-Verlag, Berlin 1992. p. 217-25
   Google Scholar
• Fresta M, Puglisi G. Corticosteroid dermal delivery with skin-lipid liposomes. J Control Rel 1997;44:141-51
   Web of Science ®Google Scholar
• Yu HY, Liao HM. Triamcinolone permeation from different liposome formulations through rat skin in vitro. Int J Pharm 1996;127:1-7
   Web of Science ®Google Scholar
• Erdogan M, Wright JR, McAlister VC. Liposomal tacrolimus lotion as a novel topical agent for immune-mediated skin disorders: experimental studies in a murine model. Br J Dermatol 2002;146:964-7
   PubMed Web of Science ®Google Scholar
• Gesztes A, Mezei M. Topical anesthesia of skin by liposome-encapsulated tetracaine. Aneth Analg 1988;67:1079-81
   PubMed Web of Science ®Google Scholar
• Foldvari M, Gesztes A, Mezei M. Dermal drug delivery by liposome encapsulation: Clinical and electron microscopic studies. J Microencaps 1990;7(4):479-89
   PubMed Web of Science ®Google Scholar
• Foldvari M. In vitro cutaneous and percutaneous delivery and in vivo effecacy of tetracaine from liposomal and conventional vehicles. Pharm Res 1994;11(11):1593-8
   PubMed Web of Science ®Google Scholar
• Hung OR, Comeau L, Riley MR, et al. Comparative topical anaesthesia of EMLA and liposome-encapsulated tetracaine. Can. J Anaesth 1997;44:707-11
   Google Scholar
• Fisher R, Hung O, Mezei M, Stewart R. Topical anaesthesia of intact skin: Liposome-encapsulated tetracaine vs EMLA. Br J Anaesth 1998;81:972-3
   PubMed Web of Science ®Google Scholar
• Planas ME, Gonzalez P, Rodriguez L, et al. Noninvasive percutaneous induction of topical analgesia by a new type of drug carrier, and prolongation of local pain insensitivity by anesthetic liposomes. Aneth Analg 1992;75:615-21
   PubMed Web of Science ®Google Scholar
• El Maghraby GM, Williams AC, Barry BW. Skin delivery of 5-fluorouracil from ultradeformable and standard liposomes in vitro. J Pharm Pharmacol 2001;53:1069-77
   PubMed Web of Science ®Google Scholar
• Cevc G, Blume G, Schätzlein A. Transfersomes-mediated transepidermal delivery improves the regio-specificity and biological activity of corticosteroids in vivo. J Control Rel 1997;45:211-26
   Web of Science ®Google Scholar
• Manosroi A, Jantrawut P, Manosroi J. Anti-inflammatory activity of gel containing novel elastic niosomes entrapped with diclofenac diethylammonium. Int J Pharm 2008;360:156-63
   PubMed Web of Science ®Google Scholar
• Lauer AC, Ramachandran C, Leib LM, et al. Targeted delivery to pilosebaceous unit via liposomes. Advanced Drug Del Rev 1996;18:311-24
   Web of Science ®Google Scholar
• Lauer AC. Percutaneous drug delivery to the hair follicle. Third edition. In: Bronaugh RL, Maibach HI, editors, Percutaneous Absorption Drugs-Cosmetics-Mechanisms-Methodology, Marcel Dekker, Inc., New York. Basel, 1999. p. 427-49
   Google Scholar
• Lieb LM, Ramachandran C, Egbaria K, Weiner N. Liposomally encapsulated active ingredients penetrate through the hair follicle. In: Falco OB, Korting HC, Maibach HI, editors, Liposome Dermatics, Springer-Verlag, Berlin, 1992. p. 200-205
   Google Scholar
• Lieb LM, Ramachandran C, Egbaria K, Weiner N. Topical delivery enhancement with multilamellar liposomes into pliosebaceous units: I. In vitro evaluation using fluorescent techniques with hamster ear model. J Invest Dermatol 1992;99(1):108-13
   PubMed Web of Science ®Google Scholar
• Lieb LM, Flynn G, Weiner N. Follicular (pilosebaceous unit) deposition and pharmacological behavior of cimetidine as a function of formulation. Pharm Res 1994;11(10):1419-23
   PubMed Web of Science ®Google Scholar
• Touitou E, Schaffer FL, Dayan N, et al. Modulation of caffeine delivery by carrier design: liposomes versus permeation enhancers. Int J Pharm 1994;103:131-6
   Web of Science ®Google Scholar
• Tschan T, Steffen H, Supersaxo A. Sebaceous-gland deposition of isotretinoin after topical application: an in vitro study using human facial skin. Skin Pharmacol 1997;10:126-34
   PubMedGoogle Scholar
• Skalko N, Cajkovac M, Jalsenjak I. Liposomes with clindamycin hydrochloride in therapy of acne vulgaris. Int J Pharm 1992;85:97-101
   Web of Science ®Google Scholar
• Meybeck A. Comedolytic activity of liposomal antiacne drug in an experimental model. In: Falco OB, Korting HC, Maibach HI, editors, Liposome Dermatics, Springer-Verlag, Berlin, 1992. p. 235-41
   Google Scholar
• Tabbakhian M, Tavakoli N, Jaafari MR, Daneshamouz S. Enhancement of follicular delivery of finasteride by liposomes and niosomes. 1. In vitro permeation and in vivo deposition studies using hamster flank and ear models. Int J Pharm 2006;323:1-10
   PubMed Web of Science ®Google Scholar
• Ganesan MG, Weiner ND, Flynn GL, Ho NFH. Influence of liposomal drug entrapment on percutaneous absorption. Int J Pharm 1984;20:139-54
   Web of Science ®Google Scholar
• Bonina FB, Montenegro L, Scrofani N, et al. Effects of phospholipid based formulations on in vitro and in vivo percutaneous absorption of methyl nicotinate. J Control Rel 1995;34:53-63
   Web of Science ®Google Scholar
• Fresta M, Puglisi G. Application of liposomes as potential cutaneous drug delivery systems. In vitro and in vivo investigation with radioactivity labelled vesicles. J Drug Target 1996;4:95-101
   PubMed Web of Science ®Google Scholar
• Simoes SI, Martins MBF, Cruz MEM, Cevc G. Anti-inflammatory effects of Cu, Zn-superoxide dismutase in liposomes, Transfersomes or micelles, in the acute murine ear edema model. In: Brain KR, Walters KA, editors, Perspectives in Percutaneous Penetration, sixth International Conference, Vol. 6a, STS Publishing, Cardiff, 1998. p. 50
   Google Scholar
• El Maghraby GM, Williams AC, Barry BW. Skin delivery of oestradiol from deformable and traditional liposomes: Mechanistic studies. J Pharm Pharmacol 1999;51:1123-34
   PubMed Web of Science ®Google Scholar
• El Maghraby GM, Williams AC, Barry BW. Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration. Int J Pharm 2000;196:63-74
   PubMed Web of Science ®Google Scholar
• El Maghraby GM, Williams AC, Barry BW. Interactions of surfactants (edge activators) and skin penetration enhancers with liposomes. Int J Pharm 2004;276:143-61
   PubMed Web of Science ®Google Scholar
• Cevc G. Rational for the production and dermal application of lipid vesicles. In: Falco OB, Korting HC, Maibach HI, editors, Liposome Dermatics, Springer-Verlag, Berlin, 1992. p. 82-90
   Google Scholar
• Cevc G. Material transport across the permeability barriers by means of lipid vesicles. In: Lipowsky R, Sackmann E, editors, Handbook of Biological Physics, Vol. 1, Elsevier Science B.V., North Holland, Amsterdam, 1995. p. 465-90
   Google Scholar
• Cevc G. Transfersomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery. Crit Rev Ther Drug Car Sys 1996;13(3&4):257-388
   PubMed Web of Science ®Google Scholar
• Honeywell-Nguyen PL, Arenja S, Bouwstra JA. Skin penetration and mechanisms of action in the delivery of the D2-agonist rotigotine from surfactant-based elastic vesicle formulations. Pharm Res 2003;20(10):1619-25
   PubMed Web of Science ®Google Scholar
• Honeywell-Nguyen PL, Gooris GS, Bouwstra JA. Quantitative assessment of the transport of elastic and rigid vesicle components and a model drug from these vesicle formulations into human skin in vivo. J Invest Dermatol 2004;123(5):902-10
   PubMed Web of Science ®Google Scholar
• Weiner N, Williams N, Birch G, et al. Topical delivery of liposomally encapsulated interferon evaluated in cutaneous herpes guinea pig model. Antimicrob Agents Chemother 1989;33(8):1217-21
   PubMed Web of Science ®Google Scholar
• Egbaria K, Ramachandran C, Kittayanond D, Weiner N. Topical delivery of liposomally encapsulated interferon evaluated by in vitro diffusion studies. Antimicrob Agents Chemother 1990;34(1):107-10
   PubMed Web of Science ®Google Scholar
• Egbaria K, Ramachandran C, Weiner N. Topical delivery of cyclosporin: evaluation of various formulations using in vitro diffusion studies in hairless mouse skin. Skin Pharmacol 1990;3:21-8
   PubMedGoogle Scholar
• Du Plessis J, Egbaria K, Ramachandran C, Weiner ND. Topical delivery of liposomally encapsulated gamma-interferon. Antiviral Res 1992;18:259-65
   PubMed Web of Science ®Google Scholar
• Artman C, Roding J, Ghyczy M, Prazel HG. Liposomes from soya phospholipids as percutaneous drug carriers: Qualitative in vivo investigations with antibody-loaded liposomes. Arzneium Forsch Drug Res 1990;40(II):1363-1365
   PubMed Web of Science ®Google Scholar
• Artman C, Roding J, Ghyczy M, Prazel HG. Liposomes from soya phospholipids as percutaneous drug carriers: Quantitative in vivo investigations with radioactivity labelled liposomes. Arzneium. Forsch Drug Res 1990;40(II):1365-68
   PubMed Web of Science ®Google Scholar
• Short SM, Paasch BD, Turner JH, et al. Percutaneous absorption of biologically-active interferon-gamma in a human skin graft-nude mouse model. Pharm Res 1996;13(7):1020-7
   PubMed Web of Science ®Google Scholar
• Cevc G, Schätzlein A, Gebauer D, Blume G. Ultra-high efficiency of drug and peptide transfer through the intact skin by means of novel drug-carriers, transfersomes. In: Brain KR, James VA, Walters KA, editors, Prediction of Percutaneous Penetration, Third International Conference, 14-16 April, Vol. 3b, STS Publishing, Cardiff, 1993. p. 226-36
   Google Scholar
• Cevc G, Schätzlein A, Blume G. Transdermal drug carriers: basic properties, optimization and transfer efficiency in the case of epicutaneously applied peptides. J Control Rel 1995;36:3-16
   Web of Science ®Google Scholar
• Cevc G, Gebauer D, Stieber J, et al. Ultraflexible vesicles, Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. Biochim Biophys Acta 1998;1368:201-15
   PubMed Web of Science ®Google Scholar
• Song YK, Kim CK. Topical delivery of low-molecular-weight heparinwith surface-charged flexible liposomes. Biomaterials 2006;27:271-80
   PubMed Web of Science ®Google Scholar
• Paul A, Cevc G, Bachhawat BK. Transdermal immunisation with an integral membrane component, gap junction protein, by means of ultradeformable drug carriers, Transfersomes. Vaccine 1998;16:188-95
   PubMed Web of Science ®Google Scholar
• Gupta PN, Mishra V, Rawat A, et al. Non-invasive vaccine delivery in transfersomes, niosomes and liposomes: a comparative study. Int J Pharm 2005;293:73-82
   PubMed Web of Science ®Google Scholar
• Mishra V, Mahor S, Rawat A, et al. Development of novel fusogenic vesosomes for transcutaneous immunization. Vaccine 2006;24:5559-70
   PubMed Web of Science ®Google Scholar
• Vyas SP, Singh RP, Jain S, et al. Non-ionic surfactant based vesicles (niosomes) for non-invasive topical genetic immunization against hepatitis B. Int J Pharm 2005;296:80-86
   PubMed Web of Science ®Google Scholar
• Mahor S, Rawat A, Dubey PK, et al. Cationic transfersomes based topical genetic vaccine against hepatitis B. Int J Pharm 2007;340: 13-19
   PubMed Web of Science ®Google Scholar
• Mishra D, Dubey V, Asthana A, et al. Elastic liposomes mediated transcutaneous immunization against Hepatitis B. Vaccine 2006;24:4847-55
   PubMed Web of Science ®Google Scholar
• Mishra D, Mishra PK, Dubey V, et al. Evaluation of uptake and generation of immune response by murine dendritic cells pulsed with hepatitis B surface antigen-loaded elastic liposomes. Vaccine 2007;25(39-40):6939-44
   PubMed Web of Science ®Google Scholar
• Mishra D, Mishra PK, Dubey V, et al. Systemic and mucosal immune response induced by transcutaneous immunization using Hepatitis B surface antigen-loaded modified liposomes. Eur J Pharm Sci 2008;33:424-33
   PubMed Web of Science ®Google Scholar
• Kato A, Ishibashi Y, Miyake Y. Effect of egg yolk lecithin on transdermal delivery of bunazosin hydrochloride. J Pharm Pharmacol 1987;39:399-400
   PubMed Web of Science ®Google Scholar
• Hofland HEJ, Bouwstra JA, Bodde HE, et al. Interaction between liposomes and human stratum corneum in vitro: freeze fracture electron microscopical visualization and small angle X-ray scattering studies. Br J Dermatol 1995;132:853-66
   PubMed Web of Science ®Google Scholar
• Korting HC, Stolz W, Schmid MH, Maierhofer G. Interaction of liposomes with human epidermis reconstructed in vitro. Britsh J Dermatol 1995;132:571-9
   PubMed Web of Science ®Google Scholar
• Zellmer S, Pfeil W, Lasch J. Interaction of phosphatidylcholine liposomes with the human stratum corneum. Biochim Biophys Acta 1995;1237:176-82
   PubMed Web of Science ®Google Scholar
• Kirjavainen M, Urtti A, Jaaskelainen I, et al. Interaction of liposomes with human skin in vitro – the influence of lipid composition and structure. Biochim Biophys Acta 1996;1304:179-89
   PubMed Web of Science ®Google Scholar
• Kirjavainen M, Urtti A, Koskela RV, et al. Liposome-skin interactions and their effects on the skin permeation of drugs. Eur J Pharm Sci 1999;7:279-86
   PubMed Web of Science ®Google Scholar
• Yokomizo Y, Sagitani H. Effects of phospholipids on the percutaneous penetration of indomethacin through the dorsal skin of the guinea pig, in vitro. J Control Rel 1996;38:267-74
   Web of Science ®Google Scholar
• Yokomizo Y, Sagitani H. Effects of phospholipids on the percutaneous penetration of indomethacin through the dorsal skin of the guinea pig, in vitro. 2. The effects of hydrophobic group in the phosphlipids and a comparison with general enhancers. J Control Rel 1996;42:37-46
   Web of Science ®Google Scholar
• Jacobs M, Martin GP, Marriott C. Effects of phosphatidylcholine on the topical bioavailability of corticosteroids assessed by the human skin blanching assay. J Pharm Pharmacol 1988;40:829-33
   PubMed Web of Science ®Google Scholar
• Du Plessis J, Weiner N, Muller DG. The influence of in vivo treatment of skin with liposomes on the topical absorption of a hydrophilic and a hydrophobic drug in vitro. Int J Pharm 1994;103:R1-5
   Web of Science ®Google Scholar
• El Maghraby GM, Williams AC, Barry BW. Skin delivery of oestradiol from lipid vesicles: importance of liposome structure. Int J Pharm 2000;204:159-69
   PubMed Web of Science ®Google Scholar
• Kim MK, Chung SJ, Lee MH, et al. Targeted and sustained delivery of hydrocortisone to normal and stratum corneum-removed skin without enhanced skin absorption using a liposome gel. J Control Rel 1997;46:243-51
   Web of Science ®Google Scholar
• Kirjavainen M, Monkkonen J, Saukkosaari M, et al. Phospholipids affect stratum corneum lipid bilayer fluidity and drug partitioning into the bilayers. J Control Rel 1999;58:207-14
   PubMed Web of Science ®Google Scholar
• Keith AD, Snipes W. Phospholipids as moisturizing agents. In: Frost P, Horovitz S, editors, Principles of Cosmetics for the Dermatologist, The C.V. Mosby Company: St. Louis, 1982. p. 59-69
   Google Scholar
• Korting HC, Zeinicke H, Schafer KM, Falco OB. Liposome encapsulation improves efficacy of betamethasone dipropionate in atopic eczema but not in psoriasis vulgaris. Eur J Clin Pharmacol 1990;39:349-51
   PubMed Web of Science ®Google Scholar
• Lasch J, Laub R, Wohlrab W. How deep do intact liposomes penetrate into human skin? J Control Rel 1991;18:55-8
   Web of Science ®Google Scholar
• Du Plessis J, Ramachandran C, Weiner N, Muller DG. The influence of particle size of liposomes on the disposition of drug into skin. Int J Pharm 1994;103:277-82
   Web of Science ®Google Scholar
• Masini V, Bonte F, Meybeck A, Wepierre J. Cutaneous bioavailability in hairless rats of tretinoin liposomes or gel. J Pharm Sci 1993;82(1):17-21
   PubMed Web of Science ®Google Scholar
• Valenta C, Janisch M. Permeation of cyproterone acetate through pig skin from different vehicles with phospholipids. Int J Pharm 2003;258:133-9
   PubMed Web of Science ®Google Scholar
• Verma DD, Verma S, Blume G, Fahr A. Particle size of liposomes influences dermal delivery of substance into skin. Int J Pharm 2003;258:141-51
   PubMed Web of Science ®Google Scholar
• Trotta M, Peira E, Debernardi F, Gallarate M. Elastic liposomes for skin delivery of dipotassium glycyrrhizinate. Int J Pharm 2002;241:319-27
   PubMed Web of Science ®Google Scholar
• Cevc G, Schätzlein A, Richardsen H. Ultradeformable lipid vesicles can penetrate skin and other semi-permeable membrane barriers unfragmented. Evidence from double label CLSM experiments and direct size measurement. Biochim Biophys Acta 2002;1564:21-30
   PubMed Web of Science ®Google Scholar
• Cevc G, Gebauer D. Hydration-driven transport of deformable lipid vesicles through fine pores and skin barrier. Biophys J 2003;84:1010-24
   PubMed Web of Science ®Google Scholar
• Honeywell-Nguyen PL, Wouter Groenink HW, de Graaff AM, Bouwstra JA. The in vivo transport of elastic vesicles into human skin: effects of occlusion, volume and duration of application. J Control Rel 2003;90(2):243-55
   PubMed Web of Science ®Google Scholar
• Schramlova J, Blazek K, Bartackova M, et al. Electron microscopic demonstration of the penetration of liposomes through skin. Folia Biol 1997;43(4):165-9
   PubMed Web of Science ®Google Scholar
• El Maghraby GM, Williams AC, Barry BW. Skin hydration and possible shunt route penetration in controlled skin delivery of estradiol from ultradeformable and standard liposomes in vitro. J Pharm Pharmacol 2001;53:1311-22
   PubMed Web of Science ®Google Scholar
• Han I, Kim M, Kim J. Enhanced transfollicular delivery of adriamycin with a liposome and iontophoresis. Exp Dermatol 2004;13(2):86-92
   PubMed Web of Science ®Google Scholar
• Cevc G, Blume G, Schätzlein A, et al. The skin: a pathway for systemic treatment with patches and lipid-based agent carriers. Advanced Drug Del Rev 1996;18:349-78
   Web of Science ®Google Scholar